Immune Design CS (IMDZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMDZ | ORGO | SLN | ||
| Company | Immune Design CS | Organogenesis Holdings Inc | Silence Therapeutics Plc ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.84 | 2.28 | 5.36 | ||
| High | 5.85 | 2.29 | 5.94 | ||
| Low | 5.84 | 2.21 | 5.26 | ||
| Latest | 5.85 | 2.24 | 5.94 | ||
| Change | unch | -0.07 | +0.47 | ||
| % Change | unch | -3.03% | +8.59% | ||
| Volume | 103,800 | 507,200 | 285,700 | ||
| 20-Day Average Volume | 409,005 | 598,045 | 358,480 | ||
| Previous Close | 5.85 | 2.31 | 5.47 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.84 | 2.49 | 6.07 | ||
| 20-Day Raw Stochastic | 100.00% | 4.48% | 37.66% | ||
| 20-Day Relative Strength | 88.63 | 26.54 | 52.36 | ||
| Weighted Alpha | -20.50 | -48.57 | +67.43 | ||
| Today's Opinion | 88% Buy | 100% Sell | 24% Buy | ||
| Previous Opinion | 88% Buy | 100% Sell | 24% Sell | ||
| Last Month's Opinion | 56% Buy | 88% Sell | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 03/25/19 | -7.44% since 03/26/26 | +11.86% since 03/26/26 | ||
| Low | 5.84 on 04/01/19 | 2.21 on 04/02/26 | 4.75 on 03/30/26 | ||
| High | 5.85 on 04/01/19 | 2.48 on 04/01/26 | 5.94 on 04/02/26 | ||
| 1-Month | |||||
| %Chg | +0.34% since 03/01/19 | -25.33% since 03/02/26 | -0.67% since 03/02/26 | ||
| Low | 5.82 on 03/14/19 | 2.21 on 04/02/26 | 4.75 on 03/30/26 | ||
| High | 5.85 on 04/01/19 | 3.02 on 03/05/26 | 7.91 on 03/16/26 | ||
| 3-Month | |||||
| %Chg | +350.00% since 12/31/18 | -51.67% since 01/02/26 | -3.41% since 01/02/26 | ||
| Low | 1.22 on 01/03/19 | 2.21 on 04/02/26 | 4.19 on 02/12/26 | ||
| High | 5.85 on 04/01/19 | 4.66 on 01/05/26 | 7.91 on 03/16/26 | ||
| 6-Month | |||||
| %Chg | +73.08% since 10/01/18 | -47.04% since 10/02/25 | +14.23% since 10/02/25 | ||
| Low | 1.10 on 12/24/18 | 2.21 on 04/02/26 | 4.19 on 02/12/26 | ||
| High | 5.85 on 04/01/19 | 7.08 on 11/11/25 | 7.91 on 03/16/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 282,935 | 288,156 | 280,570 | ||
| Shares Outstanding, K | 48,365 | 128,641 | 47,234 | ||
| Annual Sales | 2,200,000 | 564,170,000 | 560,000 | ||
| Annual Net Income | -54,760,000 | 37,030,000 | -88,610,000 | ||
| Last Quarter Sales | 480,000 | 225,610,000 | 30,000 | ||
| Last Quarter Net Income | -13,600,000 | 43,700,000 | -11,770,000 | ||
| 60-Month Beta | 3.48 | 1.48 | 1.33 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.31 on 02/26/26 | -0.25 on 03/05/26 | ||
| Latest Earnings Date | 05/01/19 | 05/14/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 8.56 | 0.00 | ||